Today: 27 December 2025
Subscribe
Browse Category

Wall Street Updates News 17 November 2025 - 22 December 2025

BioMarin (BMRN) Stock News Today: Amicus Acquisition Fallout, BMN 349 Cut, and Fresh Wall Street Price Targets (Dec. 22, 2025)

BioMarin (BMRN) Stock News Today: Amicus Acquisition Fallout, BMN 349 Cut, and Fresh Wall Street Price Targets (Dec. 22, 2025)

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) is back in the rare-disease spotlight on December 22, 2025, as investors digest a blockbuster acquisition, a quiet pipeline pruning, and a new round of analyst price-target resets. As of 20:24 UTC (3:24 p.m. ET),
22 December 2025
 ·  ·  ·  · 
Snap Inc Stock News Today (NYSE: SNAP): Shares Hover Near $7.37 as Wall Street Stays “Hold” — Latest Forecasts, Insider Filings, and 2026 Catalysts (Dec. 17, 2025)

Snap Inc Stock News Today (NYSE: SNAP): Shares Hover Near $7.37 as Wall Street Stays “Hold” — Latest Forecasts, Insider Filings, and 2026 Catalysts (Dec. 17, 2025)

Wednesday, December 17, 2025 — Snap Inc. stock (NYSE: SNAP), the parent of Snapchat, is trading around $7.37 in early Wednesday action, keeping the shares near the lower end of their 52‑week range after a modest rebound in the prior
17 December 2025
 ·  ·  ·  ·  · 
Strategy Inc (MSTR) Stock News Today: Nasdaq 100 Reshuffle Risk, MSCI Index Fight, and Wall Street Forecasts (Dec. 12, 2025)

Strategy Inc (MSTR) Stock News Today: Nasdaq 100 Reshuffle Risk, MSCI Index Fight, and Wall Street Forecasts (Dec. 12, 2025)

Strategy Inc (NASDAQ: MSTR) is in the spotlight as index-inclusion questions collide with Bitcoin volatility. Here’s the latest news, analyst forecasts, and what to watch next. Dec. 12, 2025 — Strategy Inc (NASDAQ: MSTR), the company formerly known as MicroStrategy,
12 December 2025
 ·  ·  ·  · 
Opendoor (OPEN) News Today: Warrant Dividend, Short Seller Crackdown and Wall Street Caution — November 17, 2025

Opendoor (OPEN) News Today: Warrant Dividend, Short Seller Crackdown and Wall Street Caution — November 17, 2025

Opendoor Technologies (NASDAQ: OPEN) is back in the spotlight as a controversial warrant dividend aimed at short sellers dominates headlines, even as Morgan Stanley reiterates a Hold rating and quants flag huge hedge fund flows. Here’s everything investors need to
17 November 2025
 ·  ·  ·  ·  · 
Go toTop